FAA proposes ending special issuance for non-insulin diabetes pilots
Rule ChangesProposal removes 1959-era barrier for pilots on non-insulin diabetes drugs
Yesterday: FAA publishes proposed rule to remove NIDDM from special issuanceNew here? Follow stories to track developments over time. Create a free account to get updates when stories you care about change.
Overview
Updated 1 hour agoThe Federal Aviation Administration proposed a rule on September 4 that would let pilots with non-insulin dependent diabetes get medical certificates from examiners at the time of their exam, instead of waiting months for FAA headquarters review. The regulatory language requiring that review dates to 1959.
The proposal removes "or any other hypoglycemic drug" from the medical standards for first-, second-, and third-class airman certificates. Pilots who use insulin to manage diabetes still face the special issuance requirement, and examiners can defer higher-risk cases to FAA medical staff. The FAA estimates 3,000 applicants a year would qualify.
Why it matters
Pilots with non-insulin diabetes could get medical certificates on exam day instead of waiting months, a change first possible since 1959.
Questions about this story
Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.
No questions yet — be the first to ask.
Key Indicators
Voices
Curated perspectives — historical figures and your fellow readers.
Play
Exploring all sides of a story is often best achieved with Play.
Higher or Lower
A number from this story, against one from elsewhere in the news — guess which is bigger, then keep the chain going. 5 rounds, 3 strikes; a miss costs a strike and resets your streak.
Keyboard: ↓/L lower · ↑/H higher
0 points — sign up to put that on the leaderboard.
Connections
Sixteen names from the news. Find the four hidden groups of four. Four mistakes max.
Sign up to keep a daily streak — a new puzzle lands every day.
Exit debate?
Your progress in this debate will be lost.
- 1 Two AI personas square off on this story.
- 2 You predict who'll win each round — correct picks earn XP.
- 3 One crossfire question is yours to fire. Pick it carefully.
Couldn't generate a topic
Select Your Champions
Choose one persona for each side of the debate
DEBATE TOPIC
Choose personas with different perspectives for a more dynamic debate.
Select debater for this side:
No debate personas available right now.
Select debater for this side:
No debate personas available right now.
Who's Got This Round?
Make your prediction before the referee scores
The referee scores both sides on
Round Results
Set the Crossfire
Pick the question both personas must answer in the final round
Debate Oracle! You called every round!
Sharp Instincts! You know your debaters!
The Coin Flip Strategist! Perfectly balanced!
The Contrarian! Bold predictions!
Inverse Genius! Try betting the opposite next time!
XP Breakdown
Prediction History
Organizations Involved
US agency that regulates civil aviation, including pilot medical certification.
FAA division that reviews medical certification appeals and special issuance cases.
Timeline
January 1959 September 2026
-
FAA publishes proposed rule to remove NIDDM from special issuance
Latest RulemakingAgency proposes deleting "or any other hypoglycemic drug" from part 67 medical standards, letting examiners clear non-insulin diabetes applicants at exam time.
-
Medical standards adopt hypoglycemic drug disqualification
RegulationFAA adopts rule language treating any diabetes requiring insulin or other hypoglycemic drugs as potentially disqualifying.
Historical Context
2 moments from history that rhyme with this story — and how they unfolded.
The 1959 medical standard
The FAA adopted regulatory language treating any diabetes requiring insulin or another hypoglycemic drug as potentially disqualifying. At the time, treatment options were limited and the agency had little data on how diabetics performed as pilots.
Diabetics needed individual waivers from FAA medical staff to fly.
Created a 67-year-old framework that medical practice far outpaced. Modern treatments like metformin, GLP-1 agonists, and SGLT2 inhibitors now control most type 2 diabetes without insulin.
The exact regulatory language from 1959 is what the September 2026 proposal would change.
The diabetes treatment revolution
Metformin became the standard first-line therapy in the mid-1990s, followed by GLP-1 receptor agonists and SGLT2 inhibitors in the 2000s and 2010s. These drugs manage blood glucose effectively without the hypoglycemia risk historically associated with insulin and sulfonylureas.
Most type 2 diabetes patients gained non-insulin options with better safety profiles.
Diabetes-related cardiovascular events and severe hypoglycemia declined, changing the risk calculus for pilot certification.
The FAA cites these treatment improvements as the reason the 1959 rule no longer fits clinical reality.
